SLC10A1 allele typing detection primer and method
By using primers for SLC10A1 gene c.800C>T site genotyping and HRM analysis technology, the problems of complexity and high cost of existing detection methods are solved, achieving rapid and accurate genotype differentiation, which is suitable for the detection of SLC10A1 gene mutation-related diseases.
Patent Information
- Application Number
- CN202411156267.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-12
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing SLC10A1 genotyping methods are costly, complex, time-consuming, and prone to errors, affecting the timeliness of clinical decision-making.
Using specific SLC10A1 gene c.800C>T site genotyping primers and high-resolution melting curve analysis (HRM) technology, the three genotypes of the SLC10A1 gene were distinguished by PCR amplification and HRM analysis.
This method enables rapid, accurate, and low-cost genotyping of the SLC10A1 gene c.800C>T site, effectively distinguishing between TT, CC, and CT types, and improving the specificity and repeatability of the detection.
Smart Images

Figure CN118932045A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of molecular diagnosis, and in particular relates to a primer and method for detecting SLC10A1 allele typing. Background Art
[0002] Sodium taurocholate cotransporting polypeptide (NTCP) deficiency is a new inherited bile acid metabolism disease caused by biallelic mutations in SLC10A1. NTCP deficiency is characterized by significant and persistent hypercholelicemia in childhood and may be involved in the formation of neonatal hyperbilirubinemia, early infantile cholestasis, and cholestasis of pregnancy. Among the reported NTCP deficiency patients, the SLC10A1 gene variation c.800C>T (p.Ser267Phe) is the most common, with an allele frequency of up to 95.5%, which is absolutely dominant in the SLC10A1 variation spectrum. It is necessary to perform SLC10A1 gene analysis in patients with neonatal hyperbilirubinemia, early infantile cholestasis, and cholestasis of pregnancy with significant and persistent hypercholelicemia to exclude the possibility of NTCP deficiency.
[0003] Existing methods for SLC10A1 genotyping detection include enzyme cutting technology, first-generation sequencing technology, and suspended magnetic bead liquid phase chip technology. Enzyme cutting technology uses restriction endonucleases to treat the corresponding PCR amplified fragments, and then uses gel electrophoresis to run the gel, and the obtained bands are manually interpreted to distinguish different SLC10A1 genotypes. This method requires the purchase of special enzymes, which is costly, and the detection reaction steps are complicated and time-consuming. Manual interpretation is prone to errors; first-generation sequencing technology is time-consuming and is not suitable for large-scale clinical promotion and use; suspended magnetic bead liquid phase chip technology has high costs, complex operations, and long detection times, which may affect the timeliness of clinical decision-making. Summary of the invention
[0004] Based on this, the object of the present invention is to provide a SLC10A1 allele typing detection primer, which can simply, quickly and efficiently distinguish the three genotypes of the SLC10A1 gene c.800C>T site.
[0005] To achieve the above purpose, the present invention adopts the following technical solution.
[0006] In a first aspect of the present invention, a SLC10A1 gene c.800C>T site typing detection primer is provided, the typing primer comprises an upstream primer and a downstream primer, the upstream primer is shown as SEQ ID NO.1, and the downstream primer is shown as SEQ ID NO.2.
[0007] A second aspect of the present invention provides a method for detecting c.800C>T locus typing of the SLC10A1 gene, comprising the following steps:
[0008] (1) Extracting DNA from the sample to be tested;
[0009] (2) performing PCR amplification on the DNA using the typing detection primers described above;
[0010] (3) Perform HRM analysis on the PCR amplification products.
[0011] In some embodiments, the PCR amplification system includes the following components: a DNA template, the upstream primer, the downstream primer, dNTPs, a DNA polymerase, BSA and a fluorescent dye.
[0012] In some embodiments, the fluorescent dye is EvaGreen.
[0013] In some embodiments, the final concentration of the upstream primer and / or the downstream primer in the PCR amplification system is 0.05 μM-1 μM, preferably 0.1 μM to 0.3 μM, and more preferably 0.2 μM.
[0014] In some embodiments, the PCR amplification system includes components with the following concentrations: DNA 10ng / μl-50ng / μl, the upstream primer 0.05μM-1μM, the downstream primer 0.05μM-1μM, dNTP 10nM~20nM, DNA polymerase 0.03U / μl~0.05U / μl, BSA 4ug / μl~6ug / μl.
[0015] In some of the embodiments, the PCR amplification procedure is: 1) 95°C for 3 min to 5 min; 2) 95°C for 10 s, 58°C-60°C for 25 s; repeat step 2) for 35-40 cycles.
[0016] The third aspect of the present invention provides the use of the typing detection primers described above in the preparation of a detection kit for diseases associated with the c.800C>T mutation of the SLC10A1 gene.
[0017] In some of the embodiments, the disease associated with the SLC10A1 gene c.800C>T site mutation is sodium taurocholate cotransporting polypeptide deficiency.
[0018] In a fourth aspect of the present invention, a kit for detecting diseases associated with c.800C>T mutation of the SLC10A1 gene is provided, the kit comprising the typing detection primers as described above.
[0019] In some embodiments, the kit further comprises DNA polymerase, dNTP, and fluorescent dye.
[0020] In some of the embodiments, the disease associated with the SLC10A1 gene c.800C>T site mutation is sodium taurocholate cotransporting polypeptide deficiency.
[0021] Compared with the prior art, the present invention has the following beneficial effects:
[0022] The invention provides a SLC10A1 gene c.800C>T site typing detection primer. The typing detection primer has good amplification properties for TT type (mutant homozygote), CC type (wild-type homozygote) and CT type (heterozygote) of the SLC10A1 gene c.800C>T site under the same amplification conditions, can effectively improve the resolution of a melting curve in HRM detection, effectively distinguish TT type, CC type and CT type, can simply, quickly and efficiently realize typing detection of the SLC10A1 gene c.800C>T site, has high accuracy, good specificity, good repeatability and low cost. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 This is a representative graph of the HRM melting peaks for the SLC10A1 gene c.800C>T site typing detection using primer 4 of the present invention. DETAILED DESCRIPTION
[0024] The experimental methods in the following examples of the present invention, for which specific conditions are not specified, are generally carried out under conventional conditions, such as those described in Sambrook et al., Molecular Cloning: A Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989), or under conditions recommended by the manufacturer. The various commonly used chemical reagents used in the examples are all commercially available products.
[0025] Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention.
[0026] The terms "including" and "having" and any variations thereof of the present invention are intended to cover non-exclusive inclusions. For example, a process, method, device, product or equipment comprising a series of steps is not limited to the listed steps or modules, but may optionally include steps not listed, or may optionally include other steps inherent to these processes, methods, products or equipment.
[0027] The following is a description with reference to specific embodiments.
[0028] Example 1
[0029] For the typing detection of three genotypes (TT type, CC type, CT type) at the c.800C>T (p.Ser267Phe) site of the SLC10A1 gene, a large number of studies and screenings were carried out on multiple amplification regions, and typing detection primers that can effectively distinguish TT type, CC type, and CT type were obtained (primer 4 below).
[0030] This example uses the following four primers as examples to compare and illustrate the typing effects of different primers.
[0031] Primer 1:
[0032] SLC-100-F (SEQ ID NO.1): 5'-ccaaaatgtccaactctgtt-3';
[0033] SLC-100-R (SEQ ID NO.4): 5'-ctggaaaatcatgtagaggagg-3';
[0034] Amplification product sequence 1 (SEQ ID NO. 5): ccaaaatgtccaactctgttccaccatcctcaatgtggcctttccacctgaagtcattggaccacttttcttctttcccctcctctacatgattttccag.
[0035] Primer 2:
[0036] SLC-130-F (SEQ ID NO.6): 5'-cagcatggagactggatg-3';
[0037] SLC-130-R (SEQ ID NO.7): 5'-cccttctccaagctggaa-3';
[0038] Amplification product sequence 2 (SEQ ID NO. 8): cagcatggagactggatgccaaaatgtccaactctgttccaccatcctcaatgtggcctttccacctgaagtcattggaccacttttcttctttcccctcctctacatgattttccagcttggagaaggg.
[0039] Primer 3:
[0040] SLC-74-F (SEQ ID NO.9): 5'-aaaggccacattgagga-3';
[0041] SLC-74-R (SEQ ID NO. 10): 5'-aaagaagaaaagtggtcc-3';
[0042] Amplicon sequence 3 (SEQ ID NO. 11): aaaatgtccaactctgttccaccatcctcaatgtggcctttccacctgaagtcattggaccacttttcttcttt.
[0043] Primer 4:
[0044] SLC-44-F (SEQ ID NO.1): 5'-ccaaaatgtccaactctgtt-3';
[0045] SLC-44-R (SEQ ID NO.2): 5'-gaaaggccacattgaggat-3';
[0046] Amplified product sequence 4 (SEQ ID NO. 3): ccaaaatgtccaactctgttccaccatcctcaatgtggcctttc.
[0047] All primer pairs were synthesized by Shanghai Sangon Biotechnology Service Co., Ltd.
[0048] The above four primers were used to detect samples with known genotypes, including 21 CC samples, 20 CT samples and 13 TT samples.
[0049] The detection method includes the following steps:
[0050] (1) Extracting sample DNA: Collect peripheral blood samples from the subjects and use the Kangwei Reagent Blood Genomic DNA Extraction Kit to extract sample DNA. The operation should be carried out strictly according to the instructions.
[0051] (2) The extracted DNA was amplified by PCR using the above four primers.
[0052] The total volume of the PCR amplification reaction system was 10 μl, and the system consisted of the following components: genomic DNA (50 ng / μl) 1 μl, 0.2 μM upstream primer, 0.2 μM downstream primer, dNTP 15 nM, Klen Taq 0.4 U, Hemo Klen Taq Reaction Buffer 2 μl, BSA (5 mg / ml) 1 μl, (20×in water) 1μl, RNase-FreeddH2O 3.65μl.
[0053] The PCR amplification program was as follows: 1) 95°C for 3 minutes; 2) 95°C for 10 seconds, 60°C for 25 seconds, and step 2) was performed for 40 cycles in total.
[0054] (3) HRM analysis of PCR amplification products: The PCR amplification products were subjected to HRM detection using the Tianlong Technology fully automatic medical PCR instrument (Gentier 96R), as follows: The melting process of the PCR amplification products for HRM analysis was as follows: maintain at 95°C for 1 min, reduce to 40°C for 1 min, then heat up from 40°C to 60°C, with a melting rate of 0.02°C / s, heat up to 90°C and hold for 1 second, then reduce to 40°C and hold for 30 seconds; during the process of heating from 60°C to 90°C, the signal was detected in real time, and the signal detection frequency was 10 times / °C.
[0055] Collect data and read Tm values to determine genotypes.
[0056] The genotype melting curve peak Tm values of the four primers are as follows:
[0057] Primer 1: The Tm value range of CT type is: 78.92-79.11℃; the Tm value range of CC type is: 79.01-79.51℃; the Tm value range of TT type is: 78.67-79.00℃. The Tm values of CT type, CC type and TT type overlap, and CT type, CC type and TT type cannot be distinguished.
[0058] Primer 2: The Tm value range of CT type is: 80.34-80.45℃; the Tm value range of CC type is: 80.44-80.85℃; the Tm value range of TT type is: 80.06-80.24℃. The Tm values of CT type and CC type overlap, and CT type and CC type cannot be distinguished.
[0059] Primer 3: The Tm value range of CT type is: 78.26-78.39℃; the Tm value range of CC type is: 78.20-78.63℃; the Tm value range of TT type is: 78.10-78.31℃. The Tm values of CT type, CC type and TT type overlap, and CT type, CC type and TT type cannot be distinguished.
[0060] Primer 4: The Tm value range of CT type is 72.64-73.13℃; the Tm value range of CC type is 73.23-73.81℃; the Tm value range of TT type is 72.53-72.62℃. There is no overlapping region between the Tm values of CT type, CC type and TT type, and the three genotypes can be completely distinguished.
[0061] Therefore, the primer 4 can effectively distinguish the CT type, CC type and TT type of the SLC10A1 gene c.800C>T site. Figure 1 This is a representative graph of the HRM melting peak detected by primer 4.
[0062] Example 2
[0063] To verify the accuracy of the typing test by primer 4, 28 samples were collected and the SLC10A1 gene c.800C>T site typing test was performed using primer 4; all samples were simultaneously subjected to SLC10A1 gene c.800C>T site sequencing analysis, the samples were PCR amplified (the method was the same as in Example 1), and the products were sent to Shanghai Bioengineering Co., Ltd. for Sanger sequencing to verify the accuracy and specificity of the test results.
[0064] The method for typing detection using the primer 4 is the same as in Example 1, specifically as follows:
[0065] (1) Extracting sample DNA: Collect peripheral blood samples from the subjects and use the Kangwei Reagent Blood Genomic DNA Extraction Kit to extract sample DNA. The operation should be carried out strictly according to the instructions.
[0066] (2) Using the primer 4, the extracted DNA is amplified by PCR.
[0067] The total volume of the PCR amplification reaction system was 10 μl, and the system consisted of the following components: genomic DNA (50 ng / μl) 1 μl, 0.2 μM upstream primer, 0.2 μM downstream primer, dNTP 15 nM, Klen Taq 0.4 U, Hemo Klen Taq Reaction Buffer 2 μl, BSA (5 mg / ml) 1 μl, (20×in water) 1μl, RNase-FreeddH2O 3.65μl.
[0068] The PCR amplification program was as follows: 1) 95°C for 3 minutes; 2) 95°C for 10 seconds, 60°C for 25 seconds, and step 2) was performed for 40 cycles in total.
[0069] (3) HRM analysis of PCR amplification products: The PCR amplification products were subjected to HRM detection using the Tianlong Technology fully automatic medical PCR instrument (Gen tier 96R), as follows: The melting process of the PCR amplification products for HRM analysis was as follows: maintain at 95°C for 1 min, reduce to 40°C for 1 min, then heat up from 40°C to 60°C, with a melting rate of 0.02°C / s, heat up to 90°C and hold for 1 second, then reduce to 40°C and hold for 30 seconds; during the process of heating from 60°C to 90°C, the signal was detected in real time, with a signal detection frequency of 10 times / °C, and data was collected.
[0070] The Tm value of each sample was compared with the Tm range of the three genotypes of primer 4 in Example 1 to obtain the genotype of each sample. The Tm range is as follows: the Tm value range of CT type is: 72.64~73.13℃; the Tm value range of CC type is: 73.23~73.81℃; the Tm value range of TT type is: 72.53~72.62℃.
[0071] The detection results and sequencing results are filled in Table 1 together.
[0072] Table 1
[0073]
[0074]
[0075] The above results show that primer 4 of the present invention can effectively distinguish the CT type, CC type and TT type of the c.800C>T site of the SLC10A1 gene, and the detection result is 100% consistent with the sequencing result, with a high accuracy rate.
[0076] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.
[0077] The above-mentioned embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the patent of the present invention. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A primer for detecting c.800C>T site typing of SLC10A1 gene, characterized in that: The typing primers include an upstream primer and a downstream primer, the upstream primer is shown as SEQ ID NO.1, and the downstream primer is shown as SEQ ID NO.
2.
2. A method for detecting c.800C>T locus typing of SLC10A1 gene, characterized in that: The following steps are involved: (1) Extracting DNA from the sample to be tested; (2) performing PCR amplification on the DNA using the typing detection primers as described in claim 1; (3) Perform HRM analysis on the PCR amplification products.
3. The typing detection method according to claim 2, characterized in that: The PCR amplification system includes the following components: a DNA template, the upstream primer, the downstream primer, dNTP, a DNA polymerase, BSA and a fluorescent dye.
4. The typing detection method according to claim 3, characterized in that: The final concentration of the upstream primer and / or downstream primer in the PCR amplification system is 0.05 μM-1 μM, preferably 0.1 μM-0.3 μM, and more preferably 0.2 μM.
5. The typing detection method according to claim 2, characterized in that: The PCR amplification procedure is: 1) 95°C for 3 min to 5 min; 2) 95°C for 10 s, 58°C-60°C for 25 s; repeat step 2) for 35-40 cycles.
6. Use of the typing detection primer according to claim 1 in preparing a detection kit for diseases associated with the c.800C>T site mutation of the SLC10A1 gene.
7. The use according to claim 6, characterized in that The disease associated with the SLC10A1 gene c.800C>T site mutation is sodium taurocholate cotransporting polypeptide deficiency.
8. A SLC10A1 gene c.800C>T site mutation-related disease detection kit, characterized in that: The kit comprises the typing detection primers as claimed in claim 1.
9. The detection kit according to claim 8, characterized in that The kit also includes DNA polymerase, dNTP and fluorescent dye.
10. The detection kit according to claim 8 or 9, characterized in that: The disease associated with the SLC10A1 gene c.800C>T site mutation is sodium taurocholate cotransporting polypeptide deficiency.
Citation Information
Patent Citations
HRM (High Resolution Melting) detection method and primers for beta-casein genotyping
CN108823321A
QPCR (quantitative polymerase chain reaction) kit and method for simultaneously detecting two mutation sites on target gene
CN116970685A
Biomarkers and uses thereof in the treatment of chronic hepatitis b infection
WO2021156828A2
